<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01957930</url>
  </required_header>
  <id_info>
    <org_study_id>EPI-2012</org_study_id>
    <nct_id>NCT01957930</nct_id>
  </id_info>
  <brief_title>Intensive Insulin Treatment and Ischemic Foot Ulcer</brief_title>
  <official_title>Intensified Insulin Treatment and Skin Microcirculation; Its Relation to Ischemic Foot Ulcer in Patients With Type 1 Diabetes Mellitus: A Long-term Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to investigate the relationship between skin microvascular function and the first
      hospitalization for ischemic foot ulcer in patients with type 1 diabetes former randomized
      during 7.5 years to intensified conventional insulin treatment (ICT) compared to standard
      insulin treatment (ST).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Stockholm Diabetes Intervention Study (SDIS) aimed to determine whether intensified
      insulin treatment were feasible and led to less serious diabetic complications. 102 patients
      with type 1 diabetes mellitus were randomiz (October 1982 to March 1984) to intensified
      conventional treatment (ICT; n=48) or standard treatment (ST; n=54). The randomized SDIS
      study lasted for 7.5 years, whereas 96 patients were fully evaluated. Thereafter patients
      were assigned to their regular clinical visits.

      In the present study, 96 patients from the SDIS study were asked to participate in current
      study and to investigate their skin microcirculation, in which 72 patients agreed (ICT; n=35
      vs. ST; n=37). Exclusions criteria were; any history or ongoing ischemic foot ulcer or
      peripheral artery disease or osteoartropathy. The iontophoresis investigation took place 5.5
      years ± 2 months, after the primary randomization ceased (7.5 years). Also, nineteen healthy
      subjects participated as controls for the method of iontophoresis, with no intention to be
      followed-up. All participants (except the control subjects) were then followed-up until first
      time hospitalization for ischemic foot ulcer or until 31 december 2011.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1984</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemic Foot Ulcer</measure>
    <time_frame>Until hospitalization for ischemic foot ulcer or until 31 December 2011</time_frame>
    <description>The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microvascular Endothelial Function</measure>
    <time_frame>2 months</time_frame>
    <description>Microvascular function is measured with a single point iontophoresis after stimulation with topically applied acetylcholine (ACh) [endothelial-dependent], sodium nitroprusside (SNP) [endothelial-independent], and capsaicin [C-nociceptive dependent] vasculature response.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">72</enrollment>
  <condition>Ischemic Foot Ulcer</condition>
  <arm_group>
    <arm_group_label>Intensified insulin treatment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-treatment</arm_group_label>
    <description>Continuing with routine diabetes care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensified conventional insulin treatment</intervention_name>
    <description>The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.</description>
    <arm_group_label>Intensified insulin treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard treatment</intervention_name>
    <description>Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months</description>
    <arm_group_label>Standard-treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From the original from the Stockholm Diabetes Interventional Study (SDIS) 96 patients were
        asked to take part in this follow up study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Born 1930 or later, Type 1 diabetes appearing at age 30 or earlier and with insulin
        dependency within 1 year from diagnosis, no known abuse of alcohol or drugs,
        non-prolipherative retinopathy of any degree present, no previous photocoagulation, normal
        serum creatinine, unsatsifactory blood glucose control according to the physician in charge
        of the patients.

        Exclusion Criteria:

        Any history or ongoing ischemic foot ulcer,or peripheral artery disease,or osteoartropathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Nyström, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand. 1988;224(2):115-22.</citation>
    <PMID>3048052</PMID>
  </reference>
  <reference>
    <citation>Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304-9.</citation>
    <PMID>8147960</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 4, 2013</study_first_submitted>
  <study_first_submitted_qc>October 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2013</study_first_posted>
  <results_first_submitted>November 16, 2015</results_first_submitted>
  <results_first_submitted_qc>November 16, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2015</results_first_posted>
  <last_update_submitted>November 16, 2015</last_update_submitted>
  <last_update_submitted_qc>November 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Thomas Nystrom</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>HbA1c</keyword>
  <keyword>Iontophoresis</keyword>
  <keyword>Intensified insulin treatment</keyword>
  <keyword>Ischemic foot ulcer</keyword>
  <keyword>Type 1 diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intensified Insulin Treatment</title>
          <description>Intensified conventional insulin treatment: The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.</description>
        </group>
        <group group_id="P2">
          <title>Standard-treatment</title>
          <description>Continuing with routine diabetes care
Standard treatment: Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intensified Insulin Treatment</title>
          <description>Intensified conventional insulin treatment: The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.</description>
        </group>
        <group group_id="B2">
          <title>Standard-treatment</title>
          <description>Continuing with routine diabetes care
Standard treatment: Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="37"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" lower_limit="28" upper_limit="63"/>
                    <measurement group_id="B2" value="42" lower_limit="31" upper_limit="63"/>
                    <measurement group_id="B3" value="42" lower_limit="28" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ischemic Foot Ulcer</title>
        <description>The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code</description>
        <time_frame>Until hospitalization for ischemic foot ulcer or until 31 December 2011</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intensified Insulin Treatment</title>
            <description>Intensified conventional insulin treatment: The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.</description>
          </group>
          <group group_id="O2">
            <title>Standard-treatment</title>
            <description>Continuing with routine diabetes care
Standard treatment: Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months</description>
          </group>
        </group_list>
        <measure>
          <title>Ischemic Foot Ulcer</title>
          <description>The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microvascular Endothelial Function</title>
        <description>Microvascular function is measured with a single point iontophoresis after stimulation with topically applied acetylcholine (ACh) [endothelial-dependent], sodium nitroprusside (SNP) [endothelial-independent], and capsaicin [C-nociceptive dependent] vasculature response.</description>
        <time_frame>2 months</time_frame>
        <posting_date>11/2015</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intensified Insulin Treatment</title>
          <description>Intensified conventional insulin treatment: The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.</description>
        </group>
        <group group_id="E2">
          <title>Standard-treatment</title>
          <description>Continuing with routine diabetes care
Standard treatment: Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas Nyström</name_or_title>
      <organization>Karolinska Institutet Södersjukhuset</organization>
      <phone>+46704325214</phone>
      <email>thomas.nystrom@sodersjukhuset.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

